nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0615	0.0623	CcSEcCtD
Flurazepam—Hyperkinesia—Octreotide—thymus cancer	0.0537	0.0543	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0513	0.052	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Octreotide—thymus cancer	0.0461	0.0467	CcSEcCtD
Flurazepam—Irritability—Octreotide—thymus cancer	0.0426	0.0432	CcSEcCtD
Flurazepam—Abdominal discomfort—Octreotide—thymus cancer	0.037	0.0375	CcSEcCtD
Flurazepam—Drowsiness—Octreotide—thymus cancer	0.0344	0.0348	CcSEcCtD
Flurazepam—Flushing—Octreotide—thymus cancer	0.0287	0.029	CcSEcCtD
Flurazepam—Tension—Octreotide—thymus cancer	0.0264	0.0267	CcSEcCtD
Flurazepam—Nervousness—Octreotide—thymus cancer	0.0261	0.0264	CcSEcCtD
Flurazepam—Vision blurred—Octreotide—thymus cancer	0.0253	0.0257	CcSEcCtD
Flurazepam—Agitation—Octreotide—thymus cancer	0.0247	0.025	CcSEcCtD
Flurazepam—Syncope—Octreotide—thymus cancer	0.0241	0.0244	CcSEcCtD
Flurazepam—Palpitations—Octreotide—thymus cancer	0.0238	0.0241	CcSEcCtD
Flurazepam—Loss of consciousness—Octreotide—thymus cancer	0.0236	0.0239	CcSEcCtD
Flurazepam—Arthralgia—Octreotide—thymus cancer	0.0229	0.0232	CcSEcCtD
Flurazepam—Chest pain—Octreotide—thymus cancer	0.0229	0.0232	CcSEcCtD
Flurazepam—Anxiety—Octreotide—thymus cancer	0.0228	0.0231	CcSEcCtD
Flurazepam—Dry mouth—Octreotide—thymus cancer	0.0224	0.0227	CcSEcCtD
Flurazepam—Anaphylactic shock—Octreotide—thymus cancer	0.022	0.0222	CcSEcCtD
Flurazepam—Shock—Octreotide—thymus cancer	0.0216	0.0219	CcSEcCtD
Flurazepam—Hyperhidrosis—Octreotide—thymus cancer	0.0212	0.0215	CcSEcCtD
Flurazepam—Anorexia—Octreotide—thymus cancer	0.0209	0.0212	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Octreotide—thymus cancer	0.02	0.0202	CcSEcCtD
Flurazepam—Dyspnoea—Octreotide—thymus cancer	0.0196	0.0198	CcSEcCtD
Flurazepam—Somnolence—Octreotide—thymus cancer	0.0195	0.0198	CcSEcCtD
Flurazepam—Dyspepsia—Octreotide—thymus cancer	0.0193	0.0196	CcSEcCtD
Flurazepam—Decreased appetite—Octreotide—thymus cancer	0.0191	0.0193	CcSEcCtD
Flurazepam—Constipation—Octreotide—thymus cancer	0.0188	0.019	CcSEcCtD
Flurazepam—Feeling abnormal—Octreotide—thymus cancer	0.0181	0.0183	CcSEcCtD
Flurazepam—Gastrointestinal pain—Octreotide—thymus cancer	0.018	0.0182	CcSEcCtD
Flurazepam—Asthenia—Octreotide—thymus cancer	0.0157	0.0159	CcSEcCtD
Flurazepam—Pruritus—Octreotide—thymus cancer	0.0155	0.0157	CcSEcCtD
Flurazepam—Diarrhoea—Octreotide—thymus cancer	0.015	0.0152	CcSEcCtD
Flurazepam—Dizziness—Octreotide—thymus cancer	0.0145	0.0147	CcSEcCtD
Flurazepam—Vomiting—Octreotide—thymus cancer	0.014	0.0141	CcSEcCtD
Flurazepam—Rash—Octreotide—thymus cancer	0.0138	0.014	CcSEcCtD
Flurazepam—Dermatitis—Octreotide—thymus cancer	0.0138	0.014	CcSEcCtD
Flurazepam—Headache—Octreotide—thymus cancer	0.0138	0.0139	CcSEcCtD
Flurazepam—Nausea—Octreotide—thymus cancer	0.013	0.0132	CcSEcCtD
Flurazepam—GABRA3—neck—thymus cancer	0.00113	0.0925	CbGeAlD
Flurazepam—GABRG3—pituitary gland—thymus cancer	0.000869	0.0714	CbGeAlD
Flurazepam—GABRB1—pituitary gland—thymus cancer	0.000672	0.0552	CbGeAlD
Flurazepam—GABRA4—pituitary gland—thymus cancer	0.000606	0.0498	CbGeAlD
Flurazepam—GABRP—pituitary gland—thymus cancer	0.000602	0.0494	CbGeAlD
Flurazepam—GABRA3—thyroid gland—thymus cancer	0.000536	0.044	CbGeAlD
Flurazepam—GABRG2—pituitary gland—thymus cancer	0.000507	0.0416	CbGeAlD
Flurazepam—GABRP—lung—thymus cancer	0.000471	0.0387	CbGeAlD
Flurazepam—GABRE—cardiac atrium—thymus cancer	0.00047	0.0386	CbGeAlD
Flurazepam—GABRR2—lymph node—thymus cancer	0.000461	0.0378	CbGeAlD
Flurazepam—GABRE—pituitary gland—thymus cancer	0.000459	0.0377	CbGeAlD
Flurazepam—CYP2A6—lung—thymus cancer	0.00041	0.0337	CbGeAlD
Flurazepam—GABRB2—lung—thymus cancer	0.000397	0.0326	CbGeAlD
Flurazepam—GABRE—thyroid gland—thymus cancer	0.000396	0.0325	CbGeAlD
Flurazepam—GABRB3—pituitary gland—thymus cancer	0.000389	0.032	CbGeAlD
Flurazepam—GABRE—lung—thymus cancer	0.00036	0.0295	CbGeAlD
Flurazepam—GABRB3—thyroid gland—thymus cancer	0.000336	0.0276	CbGeAlD
Flurazepam—CYP2E1—hematopoietic system—thymus cancer	0.000334	0.0274	CbGeAlD
Flurazepam—GABRB3—lung—thymus cancer	0.000305	0.025	CbGeAlD
Flurazepam—CYP3A4—hematopoietic system—thymus cancer	0.000269	0.0221	CbGeAlD
Flurazepam—GABRA2—lymph node—thymus cancer	0.000248	0.0204	CbGeAlD
Flurazepam—GABRE—lymph node—thymus cancer	0.000246	0.0202	CbGeAlD
Flurazepam—CYP2E1—lymphoid tissue—thymus cancer	0.000235	0.0193	CbGeAlD
Flurazepam—CYP2E1—thyroid gland—thymus cancer	0.000214	0.0175	CbGeAlD
Flurazepam—CYP2E1—lung—thymus cancer	0.000194	0.0159	CbGeAlD
Flurazepam—ABCB1—hematopoietic system—thymus cancer	0.00019	0.0156	CbGeAlD
Flurazepam—ABCB1—epithelium—thymus cancer	0.000174	0.0143	CbGeAlD
Flurazepam—ABCB1—pituitary gland—thymus cancer	0.000141	0.0116	CbGeAlD
Flurazepam—ABCB1—lymphoid tissue—thymus cancer	0.000134	0.011	CbGeAlD
Flurazepam—ABCB1—bone marrow—thymus cancer	0.000122	0.01	CbGeAlD
Flurazepam—ABCB1—thyroid gland—thymus cancer	0.000122	0.00999	CbGeAlD
Flurazepam—ABCB1—lung—thymus cancer	0.00011	0.00907	CbGeAlD
Flurazepam—ABCB1—lymph node—thymus cancer	7.55e-05	0.0062	CbGeAlD
